Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | Common Stock | Options Exercise | $422K | +1.95K | +4.2% | $216.45 | 48.4K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$124K | -573 | -1.18% | $216.45 | 47.9K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $176K | +811 | +1.69% | $216.45 | 48.7K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$51.7K | -239 | -0.49% | $216.45 | 48.4K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $390K | +1.8K | +3.72% | $216.45 | 50.2K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$120K | -554 | -1.1% | $216.45 | 49.7K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $294K | +1.36K | +2.74% | $216.45 | 51K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$142K | -658 | -1.29% | $216.45 | 50.4K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $697K | +3.22K | +6.39% | $216.45 | 53.6K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$337K | -1.56K | -2.91% | $216.45 | 52K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $994K | +4.59K | +8.82% | $216.45 | 56.6K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$481K | -2.22K | -3.92% | $216.45 | 54.4K | Mar 1, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | 2024 MSU Award | Award | $0 | +12.7K | $0.00 | 12.7K | Mar 1, 2024 | Common Stock | 12.7K | $0.00 | Direct | F1 | |
transaction | AVY | 2024 PU Award | Award | $0 | +14.5K | $0.00 | 14.5K | Mar 1, 2024 | Common Stock | 14.5K | $0.00 | Direct | F2 | |
transaction | AVY | 2020 MSU Award | Options Exercise | $0 | -1.95K | -100% | $0.00* | 0 | Mar 1, 2024 | Common Stock | 1.95K | $0.00 | Direct | F3 |
transaction | AVY | 2021 MSU Award | Options Exercise | $0 | -811 | -58.39% | $0.00 | 578 | Mar 1, 2024 | Common Stock | 811 | $0.00 | Direct | F4 |
transaction | AVY | 2022 MSU Award | Options Exercise | $0 | -1.8K | -32.72% | $0.00 | 3.7K | Mar 1, 2024 | Common Stock | 1.8K | $0.00 | Direct | F5 |
transaction | AVY | 2023 MSU Award | Options Exercise | $0 | -1.36K | -24.94% | $0.00 | 4.09K | Mar 1, 2024 | Common Stock | 1.36K | $0.00 | Direct | F6 |
transaction | AVY | 2021 PU Award | Options Exercise | $0 | -3.22K | -100% | $0.00* | 0 | Mar 1, 2024 | Common Stock | 3.22K | $0.00 | Direct | F7 |
transaction | AVY | 2021 Special PU Award | Options Exercise | $0 | -4.59K | -100% | $0.00* | 0 | Mar 1, 2024 | Common Stock | 4.59K | $0.00 | Direct | F8 |
Id | Content |
---|---|
F1 | Market-leveraged stock units (MSUs) vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return. Each MSU represents a contingent right to receive one share of common stock, plus dividend equivalents accrued during the vesting period. |
F2 | Performance units (PUs) vest, at the end of fiscal year 2026, provided certain performance objectives are met as determined by the Compensation Committee in February 2027. Each PU represents a contingent right to receive one share of common stock. |
F3 | Shares reflect the vesting of the fourth tranche of MSUs granted in February 2020 at 180% of target based on our absolute total stockholder return in excess of 10% during the 2020-2023 performance period, plus dividend equivalents accrued during the period. |
F4 | Shares reflect the vesting of the third tranche of MSUs granted in March 2021 at 134% of target based on our absolute total stockholder return in excess of 10% during the 2021-2023 performance period, plus dividend equivalents accrued during the period. |
F5 | Shares reflect the vesting of the second tranche of MSUs granted in March 2022 at 94% of target based on our absolute total stockholder return during the 2022-2023 performance period, plus dividend equivalents accrued during the period. |
F6 | Shares reflect the vesting of the first tranche of MSUs granted in March 2023 at 98% of target based on our absolute total stockholder return during the 2023 performance period, plus dividend equivalents accrued during the period. |
F7 | Shares reflect the vesting of PUs granted in March 2021 at 123% of target, based 75% on the cumulative economic value added of RBIS (now Solutions Group) and 25% on our relative total stockholder return. |
F8 | Shares reflect the vesting of PUs granted in March 2021 at 183% of target, based 50% on our cumulative economic value added and 50% on our relative total stockholder return. |